Targeting Receptor Tyrosine Kinase Signalling: Avenues in the Management of Cutaneous Squamous Cell Carcinoma

Scientists discuss the relevance of receptor tyrosine kinases (RTK) signaling in the progression of cutaneous squamous cell carcinoma, and observations from clinical trials that used RTK inhibitors against cutaneous squamous cell carcinoma